Asia Pacific Optical Coherence Tomography Angiography Equipment Market

The Asia Pacific optical coherence tomography angiography equipment market is expected to reach US$ 78.64 million by 2028 from US$ 50.73 million in 2021; it is estimated to grow with a CAGR of 7.6% from 2021 to 2028.

The market growth in this region is ascribed to the rising prevalence of eye-related disorders and the increasing use of artificial intelligence in optical coherence tomography angiography However, the lack of skilled professionals and technical challenges associated with the equipment restrict the market growth.

Technology advancements, leading to OCT product innovations, are providing a lucrative opportunity for the Asia Pacific optical coherence tomography angiography equipment market growth. Through effective research and development procedures, OCT angiography can help treat common illnesses, such as choroidal neovascularization in AMD, microaneurysms and ischemia in diabetic retinopathy, occlusion and abnormalities of central and branch retinal veins, and abnormalities of optic nerve vasculature.

OCTA imaging has further improved due to technological advancements in recent years. ZEISS AngioPlex OCT Angiography is an innovative product introduced for the noninvasive imaging of retinal microvasculature, thereby revolutionizing the management of glaucoma and retinal diseases. AngioPlex enables the visualization of both vascular and structural information by using a single and noninvasive scan. It captures images with Single Scan Simplicity and FastTrac scan at the highest resolution, minimizing artifacts from blinks and other eye movements without sacrificing patient throughput. Similarly, AngioAnalytics by Optovue, Inc. measures areas of flow, non-flow in the outer retina and choroid, and vessel density. This information helps assess changes in retinal and optic disc vasculature to manage disease progression and monitor treatment response.

Portable and handheld OCT devices have been developed for settings wherein these devices have been prohibited due to their cost and size. Envisu C2300 OCT by Leica Microsystems, Germany, is the first handheld OCT scanner to receive clearance from the Food and Drug Administration (FDA). The scanner consists of an imaging probe weighing 1.5 kg, connected to a console via a 1.3-m flexible cable with the most recent iteration, the C2300, and various lenses to permit both anterior- and posterior segment imaging. The portability of all these technologies has enabled imaging of patients outside the outpatient clinic, in different positions.

The development of a handheld OCT angiography (HH-OCT-A) system could enable point of care longitudinal OCT angiography imaging and allow for new insights into retinal vascular development and pediatric retinal diseases. These systems include a contact module used to image infants during examination under anaesthetic EUAs or after surgery, two non-contact OCT systems used to image adult subjects, and a handheld probe designed to image the oral mucosa. Such advancements are likely to boost the optical coherence tomography angiography equipment market in Asia Pacific during the forecast period.

Asia Pacific Optical Coherence Tomography Angiography Equipment Market Revenue and Forecast to 2028 (US$ Million)

ASIA PACIFIC OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SEGMENTATION

The Asia Pacific optical coherence tomography angiography equipment market, based on type, has been bifurcated into handheld type and tabletop type. The Asia Pacific optical coherence tomography angiography equipment market, based on end user is segmented into hospitals, clinics, and others. Geographically, the Asia Pacific optical coherence tomography angiography equipment market is divided into India, Japan, China, Australia, South Korea and Rest of Asia Pacific.

NIDEK CO., LTD; Carl Zeiss AG, Canon Inc.; Michelson Diagnostics Ltd.; SANTEC CORPORATION; Alcon Inc.; and Topcon Corporation are among the leading companies operating in the

i